1 completed, 1 recruiting, 1 unknown. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Completed 1, Recruiting 1, Unknown 1 |
Follow Neuritis: new trials by email Literature Review of Neuritis trials Research Report on Neuritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device Peripheral Nerve Stimulation - Peripheral Nerve Disorder | Early Phase 1 | Recruiting | Nervonik | 30 | 2024-11-27 | 2026-04-13 |
| BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients BXQ-350, Placebo - Neuropathy;Peripheral, Chemotherapy-induced Peripheral Neuropathy | Early Phase 1 | Completed | Bexion Pharmaceuticals, Inc. | 21 | 2022-10-17 | 2025-01-27 |
| Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer Pentoxifylline, Placebo, FOLFOX-6 regimen - Colo-rectal Cancer, Neuropathy;Peripheral | Early Phase 1 | Unknown | Tanta University | 48 | 2022-10-11 | 2022-10-21 |
Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Mucositis (1)
Nervous System Diseases (3) · Neuromuscular Diseases (3) · Peripheral Nervous System Diseases (3) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Mouth Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
Fluorouracil (1) · Leucovorin (1) · Oxaliplatin (1) · Pentoxifylline (1)
Bexion Pharmaceuticals, Inc. (1) · Nervonik (1) · Tanta University (1)
Egypt (1) · Panama (1) · United States (1)